The Pharma Legal Handbook: Saudi

Saudi Arabia is the largest pharmaceutical market in the Middle East and a strategic priority for international companies looking to establish or expand a regional presence. The Saudi Food and Drug Authority (SFDA) has significantly strengthened its regulatory capabilities in recent years, and navigating product registration, pricing approval, and post-market requirements now demands a high level of country-specific knowledge.

The Pharma Legal Handbook: Saudi Arabia provides a structured, authoritative reference for pharmaceutical regulation in the Kingdom. It covers product registration and licensing with the SFDA, clinical trial requirements, pricing and reimbursement frameworks, pharmacovigilance obligations, manufacturing standards, marketing and promotional rules, and intellectual property protection.

Saudi Arabia's Vision 2030 programme has accelerated localisation requirements for pharmaceutical manufacturing and distribution. The handbook addresses these developments alongside the established regulatory framework, giving readers a current and complete picture of what is required to operate compliantly in the market.

If legal handbook content is updated, you will receive a free updated PDF for up to one year after purchase.